Evidence map›Paper›PMID 27521113›Full record

ArticleKidney international2016

Development of a microphysiological model of human kidney proximal tubule function.

Elijah J Weber, Alenka Chapron, Brian D Chapron, Jenna L Voellinger, Kevin A Lidberg, Catherine K Yeung, Zhican Wang, Yoshiyuki Yamaura, Dale W Hailey, Thomas Neumann and 5 more

Abstract readValidation Study
In one paragraph

Article in Kidney international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 1 pooled it
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 1 synthesis or guideline pooled it, 261 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. CaAntibodies (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Life of a Kidney Podocyte.Acta physiologica (Oxford, England) · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Review

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Elijah J WeberDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Alenka ChapronDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Brian D ChapronDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Jenna L VoellingerDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Kevin A LidbergDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Catherine K YeungDepartment of Pharmacy, University of Washington, Seattle, Washington, USA; Kidney Research Institute, University of Washington, Seattle, Washington, USA.
Zhican WangDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Yoshiyuki YamauraDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Dale W HaileyDepartment of Biological Structure, University of Washington, Seattle, Washington, USA.
Thomas NeumannNortis Inc., Seattle, Washington, USA.
Danny D ShenDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
Kenneth E ThummelDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Kimberly A MuczynskiDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Jonathan HimmelfarbDepartment of Medicine, University of Washington, Seattle, Washington, USA; Kidney Research Institute, University of Washington, Seattle, Washington, USA. Electronic address: himmej@u.washington.edu.
Edward J KellyDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA. Electronic address: edkelly@uw.edu.
University of Washington · USNortis (United States) · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Thomas James Lynch · 1985 to 2026
$296.4M
XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Sheela Sathyanarayana · 1995 to 2026
$42.5M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Pharmacological Sciences SupplementT32GM007750 · NIGMS · UNIVERSITY OF WASHINGTON · PI ATKINS, WILLIAM M · 1985 to 2023
$12.6M
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
Using iPSCs to model patient outcomes in nephrotic syndromeUH3TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2014 to 2016
$6.1M
Institute of Translational Health SciencesTL1TR000422 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$2.1M
A Tissue Engineered Human Kidney Microphysiological SystemUH2TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2012 to 2013
$2.1M
NCATS NIH HHS KL2 TR000421NCATS NIH HHS KL2 TR002317NCATS NIH HHS TL1 TR000422NCATS NIH HHS UH2 TR000504NCATS NIH HHS UH3 TR000504NCI NIH HHS P30 CA015704NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

The kidney proximal tubule is the primary site in the nephron for excretion of waste products through a combination of active uptake and secretory processes and is also a primary target of drug-induced nephrotoxicity. Here, we describe the development and functional characterization of a 3-dimensional flow-directed human kidney proximal tubule microphysiological system. The system replicates the polarity of the proximal tubule, expresses appropriate marker proteins, exhibits biochemical and synthetic activities, as well as secretory and reabsorptive processes associated with proximal tubule function in vivo. This microphysiological system can serve as an ideal platform for ex vivo modeling of renal drug clearance and drug-induced nephrotoxicity. Additionally, this novel system can be used for preclinical screening of new chemical compounds prior to initiating human clinical trials.

Indexed as

Models, BiologicalBiological Transport, ActiveCell Culture TechniquesCell SurvivalEpithelial CellsHumansKidney Tubules, ProximalRenal Eliminationcell polaritycell survivalproximal tubule

Identifiers

PMID27521113
PMCPMC4987715
OpenAlexW2505765959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.